Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Novo Nordisk A/S

+ Add to Watchlist

NOVA:GR

52.880 EUR 0.742 1.42%

As of 06:25:31 ET on 04/24/2015.

Snapshot for Novo Nordisk A/S (NOVA)

Open: 51.473 Day's Range: 51.473 - 52.880 Volume: 822
Previous Close: 52.138 52wk Range: 30.190 - 53.630 1-Yr Rtn: +65.62%

Stock Chart for NOVA

No chart data available.
  • NOVA:GR 52.880
  • 1D
  • 1M
  • 1Y
52.138
Interactive NOVA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NOVA

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 33.7035
Relative P/E vs. DAX -
Earnings Per Share (DKK) (ttm) -
Est. EPS (DKK) (12/2015) 11.7080
Est. PEG Ratio 2.2967
Market Cap (M EUR) 137,488.00
Shares Outstanding (M) 2,062.56
30 Day Average Volume 4,085
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.31%
Cash Dividend (USD) 0.5329
Dividend Ex-Date 03/19/2015
5 Year Dividend Growth 27.77%
Next Earnings Announcement 04/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NOVA

  • Revenue
  • Net Income (M/DKK)
  • Profit Margin (%)

Company Profile & Key Executives for NOVA

Novo Nordisk A/S develops, produces, and markets pharmaceutical products. The Company focuses on diabetes care and offers insulin delivery systems and other diabetes products. Novo Nordisk also works in areas such as haemostatis management, growth disorders, and hormone replacement therapy. The Company offers educational and training materials. Novo Nordisk markets worldwide.

Lars Rebien SorensenChief Executive OfficerKaare SchultzPresident/COO
Jesper BrandgaardExec VP/CFOLars Fruergaard JorgensenExec VP/CIO
More Company Profile & Key Executives for NOVA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil